HAVIX FDA Approval ANDA 212901

ANDA 212901

HAVIX

FDA Drug Application

Application #212901

Application Sponsors

ANDA 212901HAVIX

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL5MG0AMPHETAMINE SULFATEAMPHETAMINE SULFATE
002TABLET;ORAL10MG0AMPHETAMINE SULFATEAMPHETAMINE SULFATE

FDA Submissions

UNKNOWN; ORIG1AP2020-05-22STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAA
002PrescriptionAA

CDER Filings

HAVIX
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212901
            [companyName] => HAVIX
            [docInserts] => ["",""]
            [products] => [{"drugName":"AMPHETAMINE SULFATE","activeIngredients":"AMPHETAMINE SULFATE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"AMPHETAMINE SULFATE","activeIngredients":"AMPHETAMINE SULFATE","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/22\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-05-22
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.